Adial Pharmaceuticals (ADIL) Institutional Ownership $0.39 +0.01 (+1.65%) Closing price 08/28/2025 04:00 PM EasternExtended Trading$0.38 -0.01 (-1.75%) As of 08/28/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Adial Pharmaceuticals (NASDAQ:ADIL)CurrentInstitutional OwnershipPercentage16.41%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$86.08KNumber ofInstitutional Sellers(last 12 months)0 Get ADIL Insider Trade Alerts Want to know when executives and insiders are buying or selling Adial Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data ADIL Institutional Buying and Selling by Quarter Adial Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC54,508$55K0.0%+63.8%0.850% 2/13/2025 Renaissance Technologies LLC47,613$48K0.0%N/A0.743% 2/12/2025 Geode Capital Management LLC61,847$62K0.0%+36.0%0.965% 8/9/2024 Renaissance Technologies LLC34,346$39K0.0%-32.8%0.811% 5/20/2024 Virtu Financial LLC20,469$27K0.0%N/A0.484% 2/13/2024 Armistice Capital LLC159,000$296K0.0%N/A9.578% 11/9/2023 Manchester Capital Management LLC48,097$134K0.0%-96.0%3.942% 5/9/2023 Manchester Capital Management LLC1,202,452$421K0.1%N/A4.216% 11/7/2022 Virtu Financial LLC77,694$27K0.0%+142.7%0.301% 8/2/2022 Thompson Davis & CO. Inc.21,000$28K0.0%N/A0.088% 7/22/2022 Truist Financial Corp33,862$45K0.0%N/A0.142% 7/13/2022 Private Advisor Group LLC21,400$29K0.0%-37.3%0.090% 11/12/2021 Oppenheimer & Co. Inc.38,500$165K0.0%+37.5%0.190% 11/12/2021 NorthRock Partners LLC10,000$43K0.0%N/A0.049% 10/29/2021 Commonwealth Equity Services LLC36,461$156K0.0%+25.5%0.180% 9/17/2021 Virtu Financial LLC31,038$79K0.0%N/A0.153% 8/16/2021 State Street Corp48,954$125K0.0%N/A0.260% 8/13/2021 Northern Trust Corp21,873$56K0.0%N/A0.116% 8/13/2021 Geode Capital Management LLC88,246$225K0.0%+13.2%0.469% 8/13/2021 Vanguard Group Inc.585,035$1.49M0.0%+172.4%3.112% 8/11/2021 Commonwealth Equity Services LLC29,050$74K0.0%+31.7%0.155% 8/3/2021 Oppenheimer & Co. Inc.28,000$71K0.0%+93.1%0.152% (Data available from 1/1/2016 forward) ADIL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADIL shares? During the previous two years, the following institutional investors and hedge funds held shares of Adial Pharmaceuticals shares: Armistice Capital LLC ($296K), Manchester Capital Management LLC ($134K), Geode Capital Management LLC ($62K), Citadel Advisors LLC ($55K), and Renaissance Technologies LLC ($48K), Virtu Financial LLC ($27K).Learn more on Adial Pharmaceuticals' institutional investors. What percentage of Adial Pharmaceuticals' stock is owned by institutional investors? 16.41% of Adial Pharmaceuticals' stock is owned by institutional investors. Learn more on ADIL's institutional investor holdings. Which institutional investors have been buying Adial Pharmaceuticals' stock? The following institutional investors have purchased Adial Pharmaceuticals' stock in the last 24 months: Armistice Capital LLC ($159K), Renaissance Technologies LLC ($47.61K), Citadel Advisors LLC ($21.24K), Virtu Financial LLC ($20.47K), and Geode Capital Management LLC ($16.38K). How much institutional buying is happening at Adial Pharmaceuticals? Institutional investors have bought a total of 85,232 shares in the last 24 months. This purchase volume represents approximately $86.08K in transactions. Related Companies Clearside Biomedical Major Shareholders Synergy CHC Major Shareholders Mural Oncology Major Shareholders Akari Therapeutics Major Shareholders Aspire Biopharma Major Shareholders Medicus Pharma Major Shareholders Kezar Life Sciences Major Shareholders MIRA Pharmaceuticals Major Shareholders CASI Pharmaceuticals Major Shareholders Dyadic International Major Shareholders This page (NASDAQ:ADIL) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access